Hypera S.A.

HYPE3.SA · Moat type: REGULIERUNG

MoatScore

6/10

Fair Value

21 BRL (≈ 4.13 USD)

Margin of Safety

-0.1 %

Rating

BEOBACHTEN

Hypera S.A. is Brazil's leading provider of branded generics and prescription pharmaceuticals, generating revenue through a broad pharmaceutical portfolio with strong distribution presence in the Brazilian pharmacy market.

View full analysis →

🔒 Detailed AI analysis, peer comparison, capital allocation, crisis resilience & PDF report for Pro members.

Not investment advice. Analyses are research, not a recommendation. Valuations may be erroneous or incomplete. © MoatScan.ai — proprietary methodology.